Pipemidic acid is a member of the pyridopyrimidine class of antibacterials, which display some overlap in mechanism of action with analogous pyridone-containing quinolones. It was introduced in 1979 and is active against gram negative and some gram positive bacteria. It was used for gastrointestinal, biliary, and urinary infections. The marketing authorization of pipemidic acid has been suspended throughout the EU.
|AHFS/Drugs.com||International Drug Names|
|CompTox Dashboard (EPA)|
|ECHA InfoCard||100.052.283 |
|Chemical and physical data|
|Molar mass||303.32 g/mol g·mol−1|
|3D model (JSmol)|
- "Pipemidic Acid - MeSH - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2019-01-20.
- "Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics". European Medicines Agency. 11 March 2019.